About TG Therapeutics, Inc. (TGTX) data
Data as of September 30, 2026.
TG Therapeutics, Inc. (TGTX) has 30.63M shares sold short as of the latest FINRA settlement report on September 30, 2026. Short interest has increased by 1.59% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 15.03 days (days to cover).
Frequently asked questions
What is the current short interest in TGTX?
As of the latest FINRA settlement dated September 30, 2026, TGTX had approximately 30,634,421 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short TGTX?
The latest borrow fee (cost to borrow) for TGTX is 0.25% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for TGTX?
Days to cover for TGTX is approximately 15.03 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is TGTX a short squeeze candidate?
A squeeze needs shorts that are hard to close. TGTX trades about 2,038,064 shares a day and would take roughly 15.03 days to unwind current short positions, at a current borrow fee of 0.25%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.